Liver-Related Mortality Increased Nearly 20% After COVID-19 Pandemic, Varied by State.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 12, p. 39
- By:
- Publication type:
- Article
Works matching IS 23752130 AND DT 2024 AND VI 10 AND IP 12
Results: 17
1
2
Harms of FIT Screening Outweigh Benefits for Those With No History of Fecal Hemoglobin.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 12, p. 38
- By:
- Publication type:
- Article
3
'No Observed Increase' in Pancreatic Cancer Among Patients with Type 2 Diabetes on GLP-1RAs.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 12, p. 37
- By:
- Publication type:
- Article
4
'No Meaningful Difference': Zymfentra Monotherapy as Effective as Combined Therapy for IBD.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 12, p. 37
- By:
- Publication type:
- Article
5
False-Positive Shield Test 'Does Not Appear' to Correlate With Higher Non-CRC Cancer Risk.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 12, p. 36
- By:
- Publication type:
- Article
6
A Clear Liquid Diet Prior to GI Endoscopy May be 'More Important' Than Holding GLP-1RAs.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 12, p. 34
- By:
- Publication type:
- Article
7
GLP-1RAs May Offer 'Hepatoprotective' Benefit for Diabetes, Alcohol-Related Liver Disease.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 12, p. 32
- By:
- Publication type:
- Article
8
Novel Farnesoid X Receptor Agonist Safe, Reduces Liver Fat Content by up to 22.8% in MASH.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 12, p. 30
- By:
- Publication type:
- Article
9
Resuming Antiviral Therapy After Withdrawal Does Not Aff ect HBsAG Seroclearance in HBV.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 12, p. 28
- By:
- Publication type:
- Article
10
Liver Stiff ness Measurements May 'Personalize' HCC Risk, Surveillance Needs in MASLD.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 12, p. 28
- By:
- Publication type:
- Article
11
FDA Expands Approval of Stelara Biosimilar Selarsdi to Include UC, Crohn's Disease.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 12, p. 27
- Publication type:
- Article
12
Health Care Practices Must 'Have a Playbook' to Prepare for, Respond to Cyberattacks.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 12, p. 16
- By:
- Publication type:
- Article
13
Researchers Identify Genetic Biomarker Linked to Risk for Severe Ulcerative Colitis.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 12, p. 14
- By:
- Publication type:
- Article
14
Mirikizumab Bests Ustekinumab in Histologic Response at Week 52 in Crohn's.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 12, p. 12
- By:
- Publication type:
- Article
15
FDA Denies Ocaliva Full Approval in Primary Biliary Cholangitis; Safety Data Still in Play.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 12, p. 10
- Publication type:
- Article
16
'Some May Die': AGA Urges Continued Access to Conventional FMT for C. difficile Patients.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 12, p. 9
- By:
- Publication type:
- Article
17
'Change the HDV Narrative': A Call to Heighten Awareness, Prioritize Early Detection.
- Published in:
- 2024
- By:
- Publication type:
- Editorial